BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 23571382)

  • 41. Endothelial progenitor cells contribute to neovascularization of non-small cell lung cancer via histone deacetylase 7-mediated cytoskeleton regulation and angiogenic genes transcription.
    Wei Y; Zhou F; Zhou H; Huang J; Yu D; Wu G
    Int J Cancer; 2018 Aug; 143(3):657-667. PubMed ID: 29490434
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DLC-1 tumor suppressor regulates CD105 expression on human non-small cell lung carcinoma cells through inhibiting TGF-β1 signaling.
    Zhang K; Na T; Ge F; Yuan BZ
    Exp Cell Res; 2020 Jan; 386(2):111732. PubMed ID: 31770531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Oxidized LDL signals through Rho-GTPase to induce endothelial cell stiffening and promote capillary formation.
    Oh MJ; Zhang C; LeMaster E; Adamos C; Berdyshev E; Bogachkov Y; Kohler EE; Baruah J; Fang Y; Schraufnagel DE; Wary KK; Levitan I
    J Lipid Res; 2016 May; 57(5):791-808. PubMed ID: 26989083
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Forced expression of the DEK-NUP214 fusion protein promotes proliferation dependent on upregulation of mTOR.
    Sandén C; Ageberg M; Petersson J; Lennartsson A; Gullberg U
    BMC Cancer; 2013 Sep; 13():440. PubMed ID: 24073922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High expression of DEK predicts poor prognosis of gastric adenocarcinoma.
    Piao J; Shang Y; Liu S; Piao Y; Cui X; Li Y; Lin Z
    Diagn Pathol; 2014 Mar; 9():67. PubMed ID: 24650035
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis.
    Matrka MC; Watanabe M; Muraleedharan R; Lambert PF; Lane AN; Romick-Rosendale LE; Wells SI
    PLoS One; 2017; 12(5):e0177952. PubMed ID: 28558019
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Mechanisms underlying cancer growth and apoptosis by DEK overexpression in colorectal cancer.
    Lin L; Piao J; Ma Y; Jin T; Quan C; Kong J; Li Y; Lin Z
    PLoS One; 2014; 9(10):e111260. PubMed ID: 25340858
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
    Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
    Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Construction of RNA interference (RNAi) lentiviral expression vector of DEK gene and its effect on the biological behavior of liver cancer cells].
    Li SH; Hou Y; Chen Z; Wu WR; Wu CX; Sun H
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):868-875. PubMed ID: 33105933
    [No Abstract]   [Full Text] [Related]  

  • 50. DEK oncogene is overexpressed during melanoma progression.
    Riveiro-Falkenbach E; Ruano Y; García-Martín RM; Lora D; Cifdaloz M; Acquadro F; Ballestín C; Ortiz-Romero PL; Soengas MS; Rodríguez-Peralto JL
    Pigment Cell Melanoma Res; 2017 Mar; 30(2):194-202. PubMed ID: 27893188
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dek overexpression in murine epithelia increases overt esophageal squamous cell carcinoma incidence.
    Matrka MC; Cimperman KA; Haas SR; Guasch G; Ehrman LA; Waclaw RR; Komurov K; Lane A; Wikenheiser-Brokamp KA; Wells SI
    PLoS Genet; 2018 Mar; 14(3):e1007227. PubMed ID: 29538372
    [TBL] [Abstract][Full Text] [Related]  

  • 52. DEK Expression is controlled by E2F and deregulated in diverse tumor types.
    Carro MS; Spiga FM; Quarto M; Di Ninni V; Volorio S; Alcalay M; Müller H
    Cell Cycle; 2006 Jun; 5(11):1202-7. PubMed ID: 16721057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. α-TEA inhibits the growth and motility of human colon cancer cells via targeting RhoA/ROCK signaling.
    Yao J; Gao P; Xu Y; Li Z
    Mol Med Rep; 2016 Sep; 14(3):2534-40. PubMed ID: 27432222
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Smurf1 regulates tumor cell plasticity and motility through degradation of RhoA leading to localized inhibition of contractility.
    Sahai E; Garcia-Medina R; Pouysségur J; Vial E
    J Cell Biol; 2007 Jan; 176(1):35-42. PubMed ID: 17190792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [MiR-26b regulates invasion and migration of lung cancer cells through targeting hENT1 depending on RhoA/ROCK-1 pathway].
    Gao Y; Yang F
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 42(7):755-761. PubMed ID: 28844997
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Epithelial‑mesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3.
    You S; Guan Y; Li W
    Mol Med Rep; 2018 Jan; 17(1):1065-1070. PubMed ID: 29115492
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of RhoA but not ROCK induces chondrogenesis of chick limb mesenchymal cells.
    Kim MJ; Kim S; Kim Y; Jin EJ; Sonn JK
    Biochem Biophys Res Commun; 2012 Feb; 418(3):500-5. PubMed ID: 22281493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The DEK Oncoprotein Functions in Ovarian Cancer Growth and Survival.
    Hacker KE; Bolland DE; Tan L; Saha AK; Niknafs YS; Markovitz DM; McLean K
    Neoplasia; 2018 Dec; 20(12):1209-1218. PubMed ID: 30412857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 3-Hydroxyflavone inhibits human osteosarcoma U2OS and 143B cells metastasis by affecting EMT and repressing u-PA/MMP-2 via FAK-Src to MEK/ERK and RhoA/MLC2 pathways and reduces 143B tumor growth in vivo.
    Lu KH; Chen PN; Hsieh YH; Lin CY; Cheng FY; Chiu PC; Chu SC; Hsieh YS
    Food Chem Toxicol; 2016 Nov; 97():177-186. PubMed ID: 27600294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Oxycodone relieves permeability damage and apoptosis of oxygen-glucose deprivation/reoxygenation-induced brain microvascular endothelial cells through ras homolog family member A (RhoA)/ Rho-associated coiled-coil containing kinases (ROCK)/ myosin light chain 2 (MLC2) signal.
    Shao F; Han D; Shen Y; Bian W; Zou L; Hu Y; Sun W
    Bioengineered; 2022 Mar; 13(3):5205-5215. PubMed ID: 35170371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.